The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Artemisinin-Based Combination Treatment of Falciparum Malaria
Abstract
Artemisinin-based combination treatments (ACTs) are now generally accepted as the best treatments for uncomplicated falciparum malaria. They are rapidly and reliably effective. Efficacy is determined by the drug partnering the artemisinin derivative and, for artesunate–mefloquine, artemether–lumefantrine, and dihydroartemisinin–piperaquine, this usually exceeds 95%. Artesunate–sulfadoxine–pyrimethamine and artesunate–amodiaquine are effective in some areas, but in other areas resistance to the partner precludes their use. There is still uncertainty over the safety of artemisinin derivatives in the first trimester of pregnancy, when they should not be used unless there are no effective alternatives. Otherwise, except for occasional hypersensitivity reactions, the artemisinin derivatives are safe and remarkably well tolerated. The adverse effect profiles of the artemisinin-based combination treatments are determined by the partner drug. Most malaria endemic countries have now adopted artemisinin-based combination treatments as first-line treatment of falciparum malaria, but in most of these only a minority of the patients that need artemisinin-based combination treatments actually receive them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
White, N. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421682 · Cited by 1,248
Self-citationAssessment of the pharmacodynamic properties of antimalarial drugs in vivo
White, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1413 · Cited by 575
Self-citationArtesunate combinations for treatment of malaria: meta-analysis
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15162-8 · Cited by 538
Thiers, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70110-2 · Cited by 512
Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02505-8 · Cited by 500
Self-citationAntimalarial Drug Toxicity: A Review
Taylor, W. R. J., & White, N. J. (2004) · Drug Safety · doi:10.2165/00002018-200427010-00003 · Cited by 482
Self-citationAntimalarial drug resistance and combination chemotherapy
White, N. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0426 · Cited by 477
Self-citationEffects of artemisinin derivatives on malaria transmissibility
Price, R. N., Nosten, F., Luxemburger, C., ter Kuile, F. O., Paiphun, L., Price, R. N., Luxemburger, C., Chongsuphajaisiddhi, T., White, N. J., Price, R. N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91488-9 · Cited by 462
Self-citationCowman, A. F., Galatis, D., & Thompson, J. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1143 · Cited by 401
Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine
White, N. J., van Vugt, M., & Ezzet, F. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937020-00002 · Cited by 351
Self-citation
Cited by
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Wang, J., Zhang, C.-J., Chia, W. N., Loh, C. C. Y., Li, Z., Lee, Y. M., He, Y., Yuan, L.-X., Lim, T. K., Liu, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10111 · Cited by 633
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Blasco, B., Leroy, D., & Fidock, D. A. (2017) · Nature Medicine · doi:10.1038/nm.4381 · Cited by 576
Biosynthesis of Plant Isoprenoids: Perspectives for Microbial Engineering
Kirby, J., & Keasling, J. D. (2009) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.043008.091955 · Cited by 478
Mäder, P., & Kattner, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00960 · Cited by 438
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 417
Medically Useful Plant Terpenoids: Biosynthesis, Occurrence, and Mechanism of Action
Bergman, M. E., Davis, B., & Phillips, M. A. (2019) · Molecules · doi:10.3390/molecules24213961 · Cited by 407
Delves, M., Plouffe, D., Scheurer, C., Meister, S., Wittlin, S., Winzeler, E. A., Sinden, R. E., & Leroy, D. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001169 · Cited by 377
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity
Li, J., Casteels, T., Frogne, T., Ingvorsen, C., Honoré, C., Courtney, M., Huber, K. V. M., Schmitner, N., Kimmel, R. A., Romanov, R. A., et al. (2017) · Cell · doi:10.1016/j.cell.2016.11.010 · Cited by 376
Discovery, mechanisms of action and combination therapy of artemisinin
Cui, L., & Su, X.-Z. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.68 · Cited by 371
Combination therapy for visceral leishmaniasis
van Griensven, J., Balasegaram, M., Meheus, F., Alvar, J., Lynen, L., & Boelaert, M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70011-6 · Cited by 336
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion
Klonis, N., Crespo-Ortiz, M. P., Bottova, I., Abu-Bakar, N., Kenny, S., Rosenthal, P. J., & Tilley, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104063108 · Cited by 333
Malaria incidence in Myanmar 2005–2014: steady but fragile progress towards elimination
Mu, T. T., Sein, A. A., Kyi, T. T., Min, M., Aung, N. M., Anstey, N. M., Kyaw, M. P., Soe, C., Kyi, M. M., & Hanson, J. (2016) · Malaria Journal · doi:10.1186/s12936-016-1567-0 · Cited by 333
Caffeic Acid and Its Derivatives: Antimicrobial Drugs toward Microbial Pathogens
Khan, F., Bamunuarachchi, N. I., Tabassum, N., & Kim, Y.-M. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07579 · Cited by 326
Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network
Cui, L., Mharakurwa, S., Ndiaye, D., Rathod, P. K., & Rosenthal, P. J. (2015) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0007 · Cited by 305
Artemisinin-based combination therapy for treating uncomplicated malaria
Sinclair, D., Zani, B., Donegan, S., Olliaro, P., & Garner, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007483.pub2 · Cited by 286
Adult and child malaria mortality in India: a nationally representative mortality survey
Dhingra, N., Jha, P., Sharma, V. P., Cohen, A. A., Jotkar, R. M., Rodriguez, P. S., Bassani, D. G., Suraweera, W., Laxminarayan, R., & Peto, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60831-8 · Cited by 284
Antimalarial drug resistance in Africa: the calm before the storm?
Conrad, M. D., & Rosenthal, P. J. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30261-0 · Cited by 255
Drug-Resistant Malaria: The Era of ACT
Lin, J. T., Juliano, J. J., & Wongsrichanalai, C. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0099-y · Cited by 121
“Against multidrug-resistant falciparum malaria, the six-dose regimen of AL was shown to be as effective as and better tolerated than artesunate-mefloquine [ 26 ].”
BackgroundTungu, P., Magesa, S., Maxwell, C., Malima, R., Masue, D., Sudi, W., Myamba, J., Pigeon, O., & Rowland, M. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-21 · Cited by 119
“The same principle has been adopted in the strategy to preserve anti-malarial drug efficacy known as combination therapy [1,26].”
BackgroundPiola, P., Nabasumba, C., Turyakira, E., Dhorda, M., Lindegardh, N., Nyehangane, D., Snounou, G., Ashley, E. A., McGready, R., Nosten, F., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70202-4 · Cited by 99
Self-citationXiang, L., Jian, D., Zhang, F., Yang, C., Bai, G., Lan, X., Chen, M., Tang, K., & Liao, Z. (2019) · Journal of Experimental Botany · doi:10.1093/jxb/erz220 · Cited by 84
N’Guessan, R., Boko, P., Odjo, A., Knols, B., Akogbeto, M., & Rowland, M. (2009) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2009.02245.x · Cited by 69
Urban, P., & Fernandez-Busquets, X. (2014) · Current Medicinal Chemistry · doi:10.2174/09298673113206660292 · Cited by 39
Usher, J., & Haynes, K. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008259 · Cited by 27
“Multi-target therapies are gaining ground, where combinations of drugs targeting different components of disease networks are deployed with the expectation of reduced toxicity, emergence of resistance, and off-target effects [5, 6, 7].”
BackgroundSiddiqui, M. R., Willis, A., Bil, K., Singh, J., Mukomena Sompwe, E., & Ariti, C. (2015) · F1000Research · doi:10.12688/f1000research.6122.1 · Cited by 13
Metadata
- Authors
- Nosten, F., & White, N. J.
- Venue
- The American Journal of Tropical Medicine and Hygiene
- Published
- 2007-12
- Volume
- 77
- Issue
- 6_Suppl
- Pages
- 181-192
- ISSN
- 0002-9637 (ISSN-L)
- OpenAlex
- W2111813303
- Cited by
- 673
- References
- 82
- FWCI
- 36.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.